Summary

Drug Delivery Systems Market – Scope of Report
TMR’s report on the global drug delivery systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug delivery systems market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug delivery systems market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the drug delivery systems market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug delivery systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug delivery systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug delivery systems market.

The report delves into the competitive landscape of the global drug delivery systems market. Key players operating in the global drug delivery systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug delivery systems market profiled in this report.

Key Questions Answered in global drug delivery systems Market Report
• What is the sales/revenue generated by drug delivery systems across all regions during the forecast period?
• What are the opportunities in the global drug delivery systems market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Drug Delivery Systems Market – Research Objectives and Research Approach
The comprehensive report on the global drug delivery systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug delivery systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug delivery systems market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Drug Delivery Systems Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Drug Delivery Systems Market Analysis and Forecasts, 2020-2035
        4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
    5.1. Healthcare Expenditure across Key Regions / Countries
    5.2. Technological Advancements in Drug Delivery Systems
    5.3. Regulatory Scenario across Key Regions / Countries
    5.4. PORTER’s Five Forces Analysis
    5.5. PESTLE Analysis
    5.6. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
6. Global Drug Delivery Systems Market Analysis and Forecasts, By Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Type, 2020-2035
        6.3.1. Oral Drug Delivery System
            6.3.1.1. Controlled-release Drug Delivery
            6.3.1.2. Other Oral Drug Delivery
        6.3.2. Injection-based Drug Delivery System
            6.3.2.1. Injectable Drug Delivery System
            6.3.2.2. Injectable Devices
        6.3.3. Transdermal Drug Delivery System
        6.3.4. Inhalation Drug Delivery System
        6.3.5. Implantable Drug Delivery System
        6.3.6. Others
    6.4. Market Attractiveness By Type
7. Global Drug Delivery Systems Market Analysis and Forecasts, By Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Application, 2020-2035
        7.3.1. Oncological Disorders
        7.3.2. Infectious Diseases
        7.3.3. Respiratory Disorders
        7.3.4. Cardiovascular Disorders
        7.3.5. Autoimmune Disorders
        7.3.6. CNS Disorders
        7.3.7. Others
    7.4. Market Attractiveness By Application
8. Global Drug Delivery Systems Market Analysis and Forecasts, By End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By End-user, 2020-2035
        8.3.1. Hospitals
        8.3.2. Ambulatory Surgical Centers
        8.3.3. Homecare Settings
        8.3.4. Others
    8.4. Market Attractiveness By End-user
9. Global Drug Delivery Systems Market Analysis and Forecasts, By Region
    9.1. Key Findings
    9.2. Market Value Forecast By Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness By Region
10. North America Drug Delivery Systems Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast By Type, 2020-2035
        10.2.1. Oral Drug Delivery System
            10.2.1.1. Controlled-release Drug Delivery
            10.2.1.2. Other Oral Drug Delivery
        10.2.2. Injection-based Drug Delivery System
            10.2.2.1. Injectable Drug Delivery System
            10.2.2.2. Injectable Devices
        10.2.3. Transdermal Drug Delivery System
        10.2.4. Inhalation Drug Delivery System
        10.2.5. Implantable Drug Delivery System
        10.2.6. Others
    10.3. Market Value Forecast By Application, 2020-2035
        10.3.1. Oncological Disorders
        10.3.2. Infectious Diseases
        10.3.3. Respiratory Disorders
        10.3.4. Cardiovascular Disorders
        10.3.5. Autoimmune Disorders
        10.3.6. CNS Disorders
        10.3.7. Others
    10.4. Market Value Forecast By End-user, 2020-2035
        10.4.1. Hospitals
        10.4.2. Ambulatory Surgical Centers
        10.4.3. Homecare Settings
        10.4.4. Others
    10.5. Market Value Forecast By Country, 2020-2035
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Drug Delivery Systems Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Type, 2020-2035
        11.2.1. Oral Drug Delivery System
            11.2.1.1. Controlled-release Drug Delivery
            11.2.1.2. Other Oral Drug Delivery
        11.2.2. Injection-based Drug Delivery System
            11.2.2.1. Injectable Drug Delivery System
            11.2.2.2. Injectable Devices
        11.2.3. Transdermal Drug Delivery System
        11.2.4. Inhalation Drug Delivery System
        11.2.5. Implantable Drug Delivery System
        11.2.6. Others
    11.3. Market Value Forecast By Application, 2020-2035
        11.3.1. Oncological Disorders
        11.3.2. Infectious Diseases
        11.3.3. Respiratory Disorders
        11.3.4. Cardiovascular Disorders
        11.3.5. Autoimmune Disorders
        11.3.6. CNS Disorders
        11.3.7. Others
    11.4. Market Value Forecast By End-user, 2020-2035
        11.4.1. Hospitals
        11.4.2. Ambulatory Surgical Centers
        11.4.3. Homecare Settings
        11.4.4. Others
    11.5. Market Value Forecast By Country / Sub-region, 2020-2035
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country / Sub-region
12. Asia Pacific Drug Delivery Systems Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Type, 2020-2035
        12.2.1. Oral Drug Delivery System
            12.2.1.1. Controlled-release Drug Delivery
            12.2.1.2. Other Oral Drug Delivery
        12.2.2. Injection-based Drug Delivery System
            12.2.2.1. Injectable Drug Delivery System
            12.2.2.2. Injectable Devices
        12.2.3. Transdermal Drug Delivery System
        12.2.4. Inhalation Drug Delivery System
        12.2.5. Implantable Drug Delivery System
        12.2.6. Others
    12.3. Market Value Forecast By Application, 2020-2035
        12.3.1. Oncological Disorders
        12.3.2. Infectious Diseases
        12.3.3. Respiratory Disorders
        12.3.4. Cardiovascular Disorders
        12.3.5. Autoimmune Disorders
        12.3.6. CNS Disorders
        12.3.7. Others
    12.4. Market Value Forecast By End-user, 2020-2035
        12.4.1. Hospitals
        12.4.2. Ambulatory Surgical Centers
        12.4.3. Homecare Settings
        12.4.4. Others
    12.5. Market Value Forecast By Country / Sub-region, 2020-2035
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country / Sub-region

ページTOPに戻る

List of Tables/Graphs

List of Figures
Figure 01: Global Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
Figure 02: Global Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
Figure 03: Global Drug Delivery Systems Market Revenue (US$ Bn), by Oral Drug Delivery System, 2020-2035
Figure 04: Global Drug Delivery Systems Market Revenue (US$ Bn), by Injection-based Drug Delivery System, 2020-2035
Figure 05: Global Drug Delivery Systems Market Revenue (US$ Bn), by Transdermal Drug Delivery System, 2020-2035
Figure 06: Global Drug Delivery Systems Market Revenue (US$ Bn), by Inhalation Drug Delivery System, 2020-2035
Figure 07: Global Drug Delivery Systems Market Revenue (US$ Bn), by Implantable Drug Delivery System, 2020-2035
Figure 08: Global Drug Delivery Systems Market Revenue (US$ Bn), by Ohers, 2020-2035
Figure 09: Global Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
Figure 10: Global Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
Figure 11: Global Drug Delivery Systems Market Revenue (US$ Bn), by Oncological Disorders, 2020-2035
Figure 12: Global Drug Delivery Systems Market Revenue (US$ Bn), by Infectious Diseases, 2020-2035
Figure 13: Global Drug Delivery Systems Market Revenue (US$ Bn), by Respiratory Disorders, 2020-2035
Figure 14: Global Drug Delivery Systems Market Revenue (US$ Bn), by Cardiovascular Disorders, 2020-2035
Figure 15: Global Drug Delivery Systems Market Revenue (US$ Bn), by Autoimmune Disorders, 2020-2035
Figure 16: Global Drug Delivery Systems Market Revenue (US$ Bn), by CNS Disorders, 2020-2035
Figure 17: Global Drug Delivery Systems Market Revenue (US$ Bn), by Others, 2020-2035
Figure 18: Global Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
Figure 19: Global Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
Figure 20: Global Drug Delivery Systems Market Revenue (US$ Bn), by Hospitals, 2020-2035
Figure 21: Global Drug Delivery Systems Market Revenue (US$ Bn), by Ambulatory Surgical Centers, 2020-2035
Figure 22: Global Drug Delivery Systems Market Revenue (US$ Bn), by Homecare Settings, 2020-2035
Figure 23: Global Drug Delivery Systems Market Revenue (US$ Bn), by Others, 2020-2035
Figure 24: Global Drug Delivery Systems Market Value Share Analysis, By Region, 2024 and 2035
Figure 25: Global Drug Delivery Systems Market Attractiveness Analysis, By Region, 2025-2035
Figure 26: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
Figure 27: North America - Drug Delivery Systems Market Value Share Analysis, by Country, 2024 and 2035
Figure 28: North America - Drug Delivery Systems Market Attractiveness Analysis, by Country, 2025-2035
Figure 29: North America - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
Figure 30: North America - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
Figure 31: North America - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
Figure 32: North America - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
Figure 33: North America - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
Figure 34: North America - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
Figure 35: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
Figure 36: Europe - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 37: Europe - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 38: Europe - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
Figure 39: Europe - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
Figure 40: Europe - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
Figure 41: Europe - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
Figure 42: Europe - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
Figure 43: Europe - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
Figure 44: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
Figure 45: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 46: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 47: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
Figure 48: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
Figure 49: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
Figure 50: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
Figure 51: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
Figure 52: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
Figure 53: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
Figure 54: Latin America - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 55: Latin America - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 56: Latin America - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
Figure 57: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
Figure 58: Latin America - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
Figure 59: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
Figure 60: Latin America - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
Figure 61: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
Figure 62: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
Figure 63: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 64: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 65: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
Figure 66: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
Figure 67: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
Figure 68: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
Figure 69: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
Figure 70: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035